Advertisement

Should You Invest in Humacyte Before the SPAC Merger?

Investors can get an early stake in Humacyte, the biotech developing human acellular vessels, by buying shares in Alpha Healthcare Acquisition Corp. (NASDAQ: AHAC), the special acquisition company (SPAC) that plans to merge with Humacyte. In this video from Motley Fool Live, recorded on Feb. 22, Fool.com Contributors Brian Orelli and Keith Speights discuss Humacyte's prospects and whether it's more appropriate for a portfolio or a watch list. Brian Orelli: Moving onto Humacyte, the company is going public through a merger with a special acquisition company (SPAC) called Alpha Healthcare Acquisition.